Patents Assigned to Hunter-Fleming Limited
  • Patent number: 8846652
    Abstract: A steroid derivative compound of formula (I) in which: one of R1 and R2 is hydroxy and the other is hydrogen; or R1 and R2 together represent oxo; R3 is hydrogen or hydroxy; and the dotted lines represent single or double carbon-carbon bonds; and pharmaceutically acceptable salts and esters thereof are useful for the prevention or treatment of pain, for improving nerve regeneration after nerve injury or damage or disease, for the prevention or treatment of brain injury, damage or disease and for neuroprotection. Particularly useful compounds are 11-hydroxy-?4-androstene-3,17-dione and 11-oxo-?4-androstene-3,17-dione or their derivatives.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: September 30, 2014
    Assignee: Hunter-Fleming Limited
    Inventors: Ernst Wulfert, James Robert Murray, David Wynick
  • Publication number: 20130023504
    Abstract: A variety of diseases and disorders associated with the metabolic pathways involved in the activities of cyclooxygenase and the synthesis of prostaglandins, for example type 2 diabetes mellitus and its sequelae, ischemic vascular diseases, pain associated with inflammation, inflammatory skin conditions, spinal cord injury, peripheral neuropathy, multiple sclerosis, inflammatory bowel disease and rheumatoid arthritis, as well as various types of cancer may be treated or prevented by the use of an agent which selectively enhances production of 15-deoxy-prostaglandin J2.
    Type: Application
    Filed: August 3, 2012
    Publication date: January 24, 2013
    Applicant: HUNTER-FLEMING LIMITED
    Inventor: ERNST WULFERT
  • Patent number: 8148355
    Abstract: 3-Hydroxy-7-hydroxy steroids and 3-oxo-7-hydroxy steroids, especially the 7?-isomers thereof, and pharmaceutically acceptable esters thereof are useful for protection against ischaemia-induced damage to peripheral organs, such as the heart or kidneys, as well as treatment of spiral cord injury.
    Type: Grant
    Filed: August 13, 2002
    Date of Patent: April 3, 2012
    Assignee: Hunter-Fleming Limited
    Inventor: Ernst Wulfert
  • Publication number: 20100173883
    Abstract: 3-Hydroxy-7?-hydroxy steroids and 3-oxo-7?-hydroxy steroids and pharmaceutically acceptable esters thereof are useful for protection against neuronal damage.
    Type: Application
    Filed: December 16, 2009
    Publication date: July 8, 2010
    Applicant: Hunter-Fleming Limited
    Inventors: Ernst Wülfert, Ashley Ker Pringle, Lars Eric Sundstrom
  • Publication number: 20100137270
    Abstract: A variety of diseases and disorders associated with the metabolic pathways involved in the activities of cyclooxygenase and the synthesis of prostaglandins, for example type 2 diabetes mellitus and its sequelae, ischemic vascular diseases, pain associated with inflammation, inflammatory skin conditions, spinal cord injury, peripheral neuropathy, multiple sclerosis, inflammatory bowel disease and rheumatoid arthritis, as well as various types of cancer may be treated or prevented by the use of an agent which selectively enhances production of 15-deoxy-prostaglandin J2.
    Type: Application
    Filed: November 29, 2007
    Publication date: June 3, 2010
    Applicant: Hunter-Fleming Limited
    Inventor: Ernst Wülfert
  • Publication number: 20100130459
    Abstract: 3-Hydroxy-7?-hydroxy steroids and 3-oxo-7?-hydroxy steroids and pharmaceutically acceptable estors thereof are useful for protection against neuronal damage.
    Type: Application
    Filed: December 15, 2009
    Publication date: May 27, 2010
    Applicant: Hunter-Fleming Limited
    Inventors: Ernst Wülfert, Ashley Ker Pringle, Lars Eric Sundstrom
  • Patent number: 7718639
    Abstract: 7-Hydroxyepiandrosterone may be used for protection against acute or chronic neuronal damage.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: May 18, 2010
    Assignee: Hunter-Fleming Limited
    Inventors: Ernst Wulfert, Ashley Ker Pringle, Lars Eric Sundstrom
  • Publication number: 20090259043
    Abstract: Compounds of formula (I): [in which: X is a group of formula >CR1R2 or >SO2; Y is a group of formula >NH or >CR1R2; Z is a group of formula >C?O or >CH2 or a direct bond; R1 is hydrogen and R2 is hydrogen, carboxy or hydroxy; or R1 and R2 together represent an oxo group, a methylenedioxy group or a hydroxyimino group; R3 is hydrogen or lower alkyl; R4 represents two hydrogen atoms, or an oxo or hydroxyimino group; R5 is hydrogen, lower alkyl or halogen; R6 is hydrogen, lower alkoxy or carboxy; R7 and R8 are each hydrogen, lower alkyl or halogen; and pharmaceutically acceptable salts and esters thereof can be used for the treatment or prophylaxis of acute or chronic neurodegenerative diseases or conditions such as Alzheimer's Disease, Parkinson's Disease, Huntington's Chorea, Multiple Sclerosis or the sequelae to acute ischaemic events such as heart attack, stroke or head injury and for protection against ischaemic damage to tissues of peripheral organs.
    Type: Application
    Filed: April 21, 2009
    Publication date: October 15, 2009
    Applicant: HUNTER-FLEMING LIMITED
    Inventors: Ernst Wulfert, Colin James Suckling, Abedawn Ibrahim Khalaf, Simon Paul Mackay, Blair Fraser Johnston
  • Publication number: 20090227551
    Abstract: A steroid derivative compound of formula (I) in which: one of R1 and R2 is hydroxy and the Vehicle other is hydrogen; or R1 and R2 together represent oxo; R3 is hydrogen or hydroxy; and the dotted lines represent single or double carbon-carbon bonds; and pharmaceutically acceptable salts and esters thereof are useful for the prevention or treatment of pain, for improving nerve regeneration after nerve injury or damage or disease, for the prevention or treatment of brain injury, damage or disease and for neuroprotection. Particularly useful compounds are 11-hydroxy-?4-androstene-3,17-dione and 11-oxo-?4-androstene-3,17-dione or their derivatives.
    Type: Application
    Filed: November 17, 2006
    Publication date: September 10, 2009
    Applicant: Hunter-Fleming Limited
    Inventors: Ernst Wulfert, James Robert Murray, David Wynick
  • Publication number: 20070231373
    Abstract: Compounds of formula (I) (in which R1; R2, R3 and R4 are the same as or different from each other and each represents an oxo group, a hydroxy group, a mercapto group, a hydrogen atom, a halogen atom, an alkoxy group or an aryloxy group; and the dotted line indicates that there may be a single or double bond between one of the respective pairs of carbon atoms) and esters thereof can be administered by transdermal administration. They are particularly effective when applied as a patch, preferably with an adhesive comprising a copolymer of from 40 to 60% by weight of methoxyethyl acrylate, from 30 to 40% by weight of lauryl acrylate or lauryl methacrylate and from 10 to 25% by weight of a polar monomer.
    Type: Application
    Filed: April 28, 2004
    Publication date: October 4, 2007
    Applicant: HUNTER-FLEMING LIMITED
    Inventors: James Murray, Fumio Kamiyama, Ernst Wulfert